How the Biopharmaceutical Industry Has Responded to COVID-19

A graphic of PhRMA's fact sheet "How the Biopharmaceutical Industry Has Responded to COVID-19"

America’s biopharmaceutical companies have successfully researched, developed and delivered multiple vaccines and therapeutics to help halt the spread and effects of COVID-19. While the positive medical and societal impact of these successes has been immense, the industry continues to innovate new ways to diagnose, treat and prevent the virus and long-term complications.

A graphic of PhRMA's fact sheet "How the Biopharmaceutical Industry Has Responded to COVID-19"